Jeffrey R. Jackson
Publications by Year
Research Areas
Microtubule and mitosis dynamics, Cancer-related Molecular Pathways, Glycosylation and Glycoproteins Research, Ubiquitin and proteasome pathways, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → An immune-active tumor microenvironment favors clinical response to ipilimumab(2011)775 cited
- → The codependence of angiogenesis and chronic inflammation(1997)695 cited
- → Targeted anti-mitotic therapies: can we improve on tubulin agents?(2007)470 cited
- → Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin(2010)368 cited
- → Antitumor activity of an allosteric inhibitor of centromere-associated protein-E(2010)254 cited
- An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage.(2000)
- Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta.(1997)
- → The Identification and Characterization of the Marine Natural Product Scytonemin as a Novel Antiproliferative Pharmacophore(2002)209 cited
- → Pharmacological Effects of SB 220025, a Selective Inhibitor of P38 Mitogen-Activated Protein Kinase, in Angiogenesis and Chronic Inflammatory Disease Models(1998)174 cited
- → Manipulation of Distinct NFκB Proteins Alters Interleukin-1β-induced Human Rheumatoid Synovial Fibroblast Prostaglandin E2 Formation(1996)172 cited